摘要:
The present disclosure relates to devices and methods of converting a bicycle frame from a mechanical gear-shifting configuration to an electronic gear-shifting configuration and vice versa. In a representative embodiment, a method of converting a bicycle frame from a mechanical gear-shifting configuration to an electronic gear-shifting configuration comprises removing a mechanical cable extending between a mechanical gear-shift actuator and a mechanical gear shifter via a cable stop of a removable bracket member secured to a down tube member of the bicycle frame, and removing the removable bracket member from the down tube member of the bicycle frame. The method further comprises mounting an electronically-actuated gear shifter to the bicycle frame in electrical communication with an electronic gear-shift actuator such that actuation of the electronic gear-shift actuator causes the electronically-actuated gear shifter to shift gears.
摘要:
The present invention is a peptide compound which stimulates the formation of hard tissues such as bone and cartilage. The invention is also related to a method to treat a defect in hard tissues such as bone and cartilage using the peptide. The method of the present invention may be used to treat or prevent the defects in bones and cartilages which are caused by rheumatoid arthritis or osteoarthritis which involves the regeneration of new bone or cartilage in or around the defects.
摘要:
A wireless network access device comprising a radio interface with a serial communication line, a switch, and M serial connections to M connectors for connecting up to M corresponding detachable radio modules. The radio interface forms up to M individually addressable radio communications paths. Each radio module includes a radio configured to communicate with client devices in a coverage area and a radio processor configured to manage at least one radio receiving buffer. The radio receiving buffers store receiver buffer identifiers to corresponding received data space. A processor manages communication between the client devices that communicate with the radio modules and a data network via the radio interface and a network interface when N
摘要:
As disclosed herein, the present invention provides for kits and a composition for diagnosis, prognosis, drug discovery, drug development, and patient stratification. The kits can comprise a plurality of binding elements for cell surface markers, and a plurality of binding elements for state-specific intracellular markers. The kits can further comprise a plurality of modulators directed for the particular cell function or signaling pathways. The kits can further include fixatives, permeabilizing agent, buffers, containers, instructions, and software for data analysis/compilation.
摘要:
Formulations and methods to promote biological processes to form or regenerate new hard tissues such as bones, cartilage, and/or dental tissues are disclosed. The formulation comprising two proteins is administered to enhance biological activities of a hard tissue growth and differentiation factor characterized by specific and selective upregulation and/or extension of the retention time of the intracellular enzymes and signaling molecules that play important roles to proliferate, differentiate, maturate, and/or mineralize the hard tissue forming cells.
摘要:
Formulations and methods to promote biological processes to form or regenerate new hard tissues such as bones, cartilage, and/or dental tissues are disclosed. The formulation enhances biological activities of a hard tissue growth and differentiation factor characterized by specific and selective upregulation and/or extension of the retention time of the intracellular enzymes and signaling molecules that play important roles to proliferate, differentiate, maturate, and/or mineralize the hard tissue forming cells.
摘要:
A method is disclosed whereby levels of calcium, phosphate and parathyroid hormone are measured in a patient. The patient is treated with a formulation comprising a compound having phosphotonin activity and thereafter measurements are made again. Dosing of the formulation is adjusted based on measurements with measuring, administering and adjusting dosing continually repeated as needed.
摘要:
A method and system are herein disclosed for registering a member at a targeted web-based information management system using a reduced amount of member and system interaction to confirm and establish the member's contact information. Generally, the method may communicate permission to solicit a potential member to the information management system. In one embodiment, the member previously communicated permission to receive solicitations from other systems to another web-based information management system. The method may communicate the permission from another web-based system to the present system. The permission may include member identification and/or demographic data. The method may communicate a solicitation message from the system to the member, the solicitation message comprising at least a portion of the member identification data. The member may then communicate a confirmation message to the targeted web-based information management system, wherein the confirmation message is in reply to the solicitation message and includes the portion of the member identification data. Using the confirmation, the system may then match the portion of the member identification data from the confirmation message to the portion of the member identification data from the confirmation message.
摘要:
The present invention is a method for promoting angiogenesis by administering a formulation comprising an effective amount of a peptidic compound, e.g., a peptide having the sequence TDLQERGDNDISPFSGDGQPFKD (SEQ ID NO: 30), which enhances angiogenesis through the induction of pro-angiogenic factors such as FGF2, TGFβ and fibronectin. Formulations may be administered by catheter to treat or prevent diseases and conditions which involve angiogenesis by administering an effective amount of the peptidic compound alone or in combination with one or more additional therapeutic agents.
摘要翻译:本发明是通过施用包含有效量的肽化合物(例如具有序列TDLQERGDNDISPFSGDGQPFKD(SEQ ID NO:30)的肽)的制剂来促进血管生成的方法,其通过诱导促血管生成因子如 如FGF2,TGFbeta和纤连蛋白。 制剂可以通过导管施用以通过单独施用有效量的肽化合物或与一种或多种另外的治疗剂组合来治疗或预防涉及血管生成的疾病和病症。